BRD2 Antikörper (Internal Region)

Produktnummer ABIN544203

Produktdetails anti-BRD2 Antikörper

Target: BRD2 (Bromodomain Containing 2 (BRD2))

Bindungsspezifität: Internal Region

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser BRD2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Verwendungszweck: Rabbit polyclonal antibody raised against synthetic peptide of BRD2.

Kreuzreaktivität: Human

Immunogen: A synthetic peptide (conjugated with KLH) corresponding to internal region of human BRD2.

Anwendungsinformationen

Applikationshinweise: Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1:50-100)
Western Blot (1:1000)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In PBS (0.09 % sodium azide)

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-BRD2 Antikörper (ABIN544203)

Asangani, Dommeti, Wang, Malik, Cieslik, Yang, Escara-Wilke, Wilder-Romans, Dhanireddy, Engelke, Iyer, Jing, Wu, Cao, Qin, Wang, Feng, Chinnaiyan: "Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer." in: Nature, Vol. 510, Issue 7504, pp. 278-82, (2014) (PubMed).

Pal, Evgrafov, Tabares, Zhang, Durner, Greenberg: "BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy." in: American journal of human genetics, Vol. 73, Issue 2, pp. 261-70, (2003) (PubMed).

Crowley, Kaine, Yoshida, Nandi, Wolgemuth: "Reproductive cycle regulation of nuclear import, euchromatic localization, and association with components of Pol II mediator of a mammalian double-bromodomain protein." in: Molecular endocrinology (Baltimore, Md.), Vol. 16, Issue 8, pp. 1727-37, (2002) (PubMed).

Denis, Vaziri, Guo, Faller: "RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F." in: Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, Vol. 11, Issue 8, pp. 417-24, (2000) (PubMed).

Details zu BRD2

Target: BRD2 (Bromodomain Containing 2 (BRD2))

Andere Bezeichnung: BRD2 (BRD2 Produkte)

Synonyme: D6S113E antikoerper, FSH antikoerper, FSRG1 antikoerper, NAT antikoerper, RING3 antikoerper, RNF3 antikoerper, AW228947 antikoerper, D17H6S113E antikoerper, Frg-1 antikoerper, Fsrg-1 antikoerper, Fsrg1 antikoerper, Nat antikoerper, Ring3 antikoerper, Rnf3 antikoerper, mKIAA4005 antikoerper, brd2-a antikoerper, fsh antikoerper, fsrg1 antikoerper, nat antikoerper, ring3 antikoerper, rnf3 antikoerper, brd2 antikoerper, fe47f02 antikoerper, fi85h05 antikoerper, wu:fe47f02 antikoerper, wu:fi85h05 antikoerper, Ring3 protein antikoerper, bromodomain containing 2 antikoerper, bromodomain containing 2 S homeolog antikoerper, bromodomain containing 2a antikoerper, CHLREDRAFT_190116 antikoerper, CHLREDRAFT_150233 antikoerper, CHLREDRAFT_182576 antikoerper, CHLREDRAFT_188250 antikoerper, BRD2 antikoerper, Brd2 antikoerper, brd2.S antikoerper, brd2a antikoerper

Gen-ID: 6046

Pathways: Chromatin Binding, SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion